Beiley Biofund Inc. (TPEX:7882)
Taiwan · Delayed Price · Currency is TWD 26.70
+0.15 (0.56%)
At close: Sep 24, 2026
Beiley Biofund Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Operating Revenue | 0.67 | 0.26 | - | - |
Other Revenue | 904.82 | 1,227 | 140.54 | 139.5 |
| 905.49 | 1,227 | 140.54 | 139.5 | |
Revenue Growth | 330.06% | 773.27% | 0.74% | - |
Gross Profit | 905.49 | 1,227 | 140.54 | 139.5 |
Selling, General & Admin | 60.57 | 72.32 | 49.82 | 57.4 |
Amortization of Goodwill & Intangibles | - | - | 0 | - |
Operating Expenses | 60.08 | 72.32 | 51.67 | 57.58 |
Operating Income | 845.41 | 1,155 | 88.87 | 81.92 |
Interest Expense | -0.09 | -0.01 | -0.04 | -0.01 |
Interest & Investment Income | 16.67 | 16.79 | 15.21 | 4.06 |
Currency Exchange Gain (Loss) | 9.55 | 0.59 | 1.44 | - |
Other Non Operating Income (Expenses) | 0.01 | 0.01 | 0.03 | 1.5 |
EBT Excluding Unusual Items | 871.55 | 1,172 | 105.51 | 87.47 |
Gain (Loss) on Sale of Investments | - | 0.36 | 6.12 | 1.15 |
Pretax Income | 871.55 | 1,173 | 111.63 | 88.63 |
Income Tax Expense | 77.61 | 47.09 | 15.12 | 0.01 |
Net Income | 793.94 | 1,126 | 96.51 | 88.62 |
Net Income to Common | 793.94 | 1,126 | 96.51 | 88.62 |
Net Income Growth | 458.48% | 1066.28% | 8.91% | - |
Shares Outstanding (Basic) | 212 | 212 | 212 | 94 |
Shares Outstanding (Diluted) | 213 | 213 | 212 | 94 |
Shares Change | 0.03% | 0.04% | 127.18% | - |
EPS (Basic) | 3.74 | 5.30 | 0.45 | 0.95 |
EPS (Diluted) | 3.73 | 5.29 | 0.45 | 0.95 |
EPS Growth | 459.66% | 1065.98% | -52.04% | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Free Cash Flow | -138.46 | -35.4 | 216.57 | -569.02 |
Free Cash Flow Per Share | -0.65 | -0.17 | 1.02 | -6.08 |
Dividend Per Share | 1.353 | 1.353 | 0.145 | - |
Dividend Growth | 833.54% | 833.54% | - | - |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% |
Operating Margin | 93.36% | 94.11% | 63.24% | 58.73% |
Profit Margin | 87.68% | 91.72% | 68.67% | 63.52% |
Free Cash Flow Margin | -15.29% | -2.89% | 154.10% | -407.90% |
EBITDA | 846.38 | 1,156 | 89.68 | 81.93 |
EBITDA Margin | 93.47% | 94.23% | 63.81% | 58.73% |
D&A For EBITDA | 0.97 | 1.49 | 0.81 | 0.01 |
EBIT | 845.41 | 1,155 | 88.87 | 81.92 |
EBIT Margin | 93.36% | 94.11% | 63.24% | 58.73% |
Effective Tax Rate | 8.91% | 4.02% | 13.55% | 0.01% |
Revenue as Reported | 905.49 | 1,227 | 140.54 | - |